CHIME Fall Forum 2024
Erin Osbourn, CIO at the Child Mind Institute, shares her experiences at the Chime Fall Forum and highlights the importance of building a culture of inclusion, belonging, and work-life harmony within her team. She discusses her leadership approach of fostering vulnerability, empathy, and balance, while emphasizing the critical need to destigmatize mental health, especially in…
Latest
CHIME Fall Forum 2024
Jesse Folds at CHIME Fall Forum
Jesse Folds, Director of IT Operations and Cybersecurity at Opelousas General, discusses the growing focus on zero trust policies, cybersecurity, and the challenges of understaffed IT departments in healthcare. He highlights the importance of vendor partnerships that understand budget cycles and emphasizes shifting ROI metrics toward improving patient satisfaction and equipping nurses with tools to…
CHIME Fall Forum 2024
Ryan Thousand at CHIME Fall Forum
Ryan Thousand, CIO of Dahl Memorial Healthcare in rural Montana, discusses the unique challenges and opportunities of leading a critical access hospital in a small community. From leveraging AI and strategic partnerships to enhance patient care and operational efficiency, to his decision to join the Panda Health family for its vendor-agnostic, community-driven approach, Ryan shares…
Latest
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…
What’s Next in Preclinical Cancer Immunotherapy Research?
As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
